Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 May;35(5):687–691. doi: 10.1136/gut.35.5.687

Combined (short-term plus longterm) sclerotherapy v short-term only sclerotherapy: a randomised prospective trial.

M Moretó 1, M Zaballa 1, E Ojembarrena 1, S Ibáñez 1, M J Suárez 1, F Setién 1, E Delgado 1
PMCID: PMC1374758  PMID: 8200567

Abstract

Short term sclerotherapy (by injection(s) around the bleeding point) is used for immediate control of massive haemorrhage from oesophagogastric varices. The usefulness of longterm sclerotherapy once short term sclerotherapy has been successfully carried out was assessed. Two treatment groups were studied: 50 patients were treated by 'combined' (short term followed by longterm) sclerotherapy; 56 patients were treated by short term sclerotherapy only. Patients included in the second group were treated by short term sclerotherapy only if a variceal rebleeding was present. The overall cumulative proportion of patients rebleeding was not significantly different in either group. Combined sclerotherapy patients, however, experienced less episodes of variceal haemorrhage and the source of haemorrhage was different (p < 0.002). Combined sclerotherapy was more efficient in preventing bleeding from oesophageal bleeding points but not those arising from a junctional source (p < 0.05). A greater incidence of oesophageal rebleeding was found in those patients whose first source of bleeding was oesophageal (p < 0.05). No significant difference was detected in survival expectancy between either group. In conclusion, after short term sclerotherapy is carried out successfully, those patients with bleeding from variceal bleeding points located on oesophageal mucosa should benefit most from a longterm sclerotherapy programme.

Full text

PDF
687

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barsoum M. S., Bolous F. I., El-Rooby A. A., Rizk-Allah M. A., Ibrahim A. S. Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices. Br J Surg. 1982 Feb;69(2):76–78. doi: 10.1002/bjs.1800690206. [DOI] [PubMed] [Google Scholar]
  2. Clark A. W., Macdougall B. R., Westaby D., Mitchell K. J., Silk D. B., Strunin L., Dawson J. L., Williams R. Prospective controlled trial of injection sclerotherapy in patient with cirrhosis and recent variceal haemorrhage. Lancet. 1980 Sep 13;2(8194):552–554. doi: 10.1016/s0140-6736(80)91990-x. [DOI] [PubMed] [Google Scholar]
  3. D'Amico G., Montalbano L., Traina M., Pisa R., Menozzi M., Spanò C., Pagliaro L. Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology. 1990 Dec;99(6):1558–1564. doi: 10.1016/0016-5085(90)90458-d. [DOI] [PubMed] [Google Scholar]
  4. Detsky A. S., Sackett D. L. When was a "negative" clinical trial big enough? How many patients you needed depends on what you found. Arch Intern Med. 1985 Apr;145(4):709–712. [PubMed] [Google Scholar]
  5. Dilawari J. B., Raju G. S., Chawla Y. K. Development of large spleno-adreno-renal shunt after endoscopic sclerotherapy. Gastroenterology. 1989 Aug;97(2):421–426. doi: 10.1016/0016-5085(89)90078-4. [DOI] [PubMed] [Google Scholar]
  6. Freedman L. S. Tables of the number of patients required in clinical trials using the logrank test. Stat Med. 1982 Apr-Jun;1(2):121–129. doi: 10.1002/sim.4780010204. [DOI] [PubMed] [Google Scholar]
  7. Moretó M., Zaballa M., Bernal A., Ibáez S., Ojembarrena E., Rodriguez A. A randomized trial of tamponade or sclerotherapy as immediate treatment for bleeding esophageal varices. Surg Gynecol Obstet. 1988 Oct;167(4):331–334. [PubMed] [Google Scholar]
  8. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Prindiville T., Trudeau W. A comparison of immediate versus delayed endoscopic injection sclerosis of bleeding esophageal varices. Gastrointest Endosc. 1986 Dec;32(6):385–388. doi: 10.1016/s0016-5107(86)71916-0. [DOI] [PubMed] [Google Scholar]
  10. Pugh R. N., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646–649. doi: 10.1002/bjs.1800600817. [DOI] [PubMed] [Google Scholar]
  11. Sarin S. K., Sreenivas D. V., Lahoti D., Saraya A. Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology. 1992 Mar;102(3):994–999. doi: 10.1016/0016-5085(92)90188-5. [DOI] [PubMed] [Google Scholar]
  12. Simon R. Confidence intervals for reporting results of clinical trials. Ann Intern Med. 1986 Sep;105(3):429–435. doi: 10.7326/0003-4819-105-3-429. [DOI] [PubMed] [Google Scholar]
  13. Terblanche J., Northover J. M., Bornman P., Kahn D., Silber W., Barbezat G. O., Sellars S., Campbell J. A., Saunders S. J. A prospective controlled trial of sclerotherapy in the long term management of patients after esophageal variceal bleeding. Surg Gynecol Obstet. 1979 Mar;148(3):323–333. [PubMed] [Google Scholar]
  14. Vianna A., Hayes P. C., Moscoso G., Driver M., Portmann B., Westaby D., Williams R. Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology. 1987 Oct;93(4):876–889. doi: 10.1016/0016-5085(87)90453-7. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES